- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Pharmaceutics, 15, (10), MDPI
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek
- (wann)
-
2024
- Urheber
-
Bitsch, Peter
Baum, Eva
Beltrán Hernández, Irati
Bitsch, Sebastian Harald
Harwood, Jakob
Oliveira, Sabrina
Kolmar, Harald
- DOI
-
10.26083/tuprints-00024648
- URN
-
urn:nbn:de:tuda-tuprints-246483
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bitsch, Peter
- Baum, Eva
- Beltrán Hernández, Irati
- Bitsch, Sebastian Harald
- Harwood, Jakob
- Oliveira, Sabrina
- Kolmar, Harald
- Universitäts- und Landesbibliothek
Entstanden
- 2024
Ähnliche Objekte (12)
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Target-Site Penetration of Active Ingredients in Human Skin
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Peptide-conjugated dextran hybrids: Generation of a versatile module for cytosolic delivery of biomolecular cargoes
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Modifikation von Proteinen mittels Photosensibilisatoren für die strukturierte Proteinimmobilisierung und Quervernetzung von Biomaterialien
Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
Modification of biomaterials for the immobilization and release of chemokines
Anti-idiotype antibodies for biomedical applications
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Target-Site Penetration of Active Ingredients in Human Skin
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Peptide-conjugated dextran hybrids: Generation of a versatile module for cytosolic delivery of biomolecular cargoes
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Modifikation von Proteinen mittels Photosensibilisatoren für die strukturierte Proteinimmobilisierung und Quervernetzung von Biomaterialien
Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
Modification of biomaterials for the immobilization and release of chemokines
Anti-idiotype antibodies for biomedical applications
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Target-Site Penetration of Active Ingredients in Human Skin
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Peptide-conjugated dextran hybrids: Generation of a versatile module for cytosolic delivery of biomolecular cargoes
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Modifikation von Proteinen mittels Photosensibilisatoren für die strukturierte Proteinimmobilisierung und Quervernetzung von Biomaterialien
Identification of novel antagonists against skin relevant molecular targets in mediation of itch and inflammation
Modification of biomaterials for the immobilization and release of chemokines